» Articles » PMID: 34988024

Postoperative Outcomes of Distal Pancreatectomy for Retroperitoneal Sarcoma Abutting the Pancreas in the Left Upper Quadrant

Overview
Journal Front Oncol
Specialty Oncology
Date 2022 Jan 6
PMID 34988024
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: En bloc resection of the tumor with adjacent organs is recommended for localized retroperitoneal sarcoma (RPS). However, resection of the pancreas is controversial because it may cause serious complications, such as pancreatic fistula or bleeding. Thus, we evaluated the outcomes of distal pancreatectomy (DP) in pancreas-abutting RPS of the left upper quadrant (LUQ).

Methods: We reviewed all consecutive patients who underwent surgery for RPS between September 2001 and April 2020. We selected 150 patients with all or part of their tumor located in the LUQ on preoperative computed tomography. Eighty-six patients who had tumors abutting the pancreas were finally enrolled in our study.

Results: Fifty-three patients (53/86; 61.6%) were included in the non-DP group, and 33 patients (33/86; 38.4%) were included in the DP group. Total postoperative complications and complication rates for those Clavien-Dindo grade 3 or higher were similar between the non-DP group and DP group (p = 0.290 and p = 0.550). In the DP group, grade B pancreatic fistulae occurred in 18.2% (6/33) of patients, but grade C pancreatic fistulae were absent, and microscopic pancreatic invasion was noted in 42.4% (14/33) of patients. During multivariate analysis, microscopic pancreatic invasion was deemed a risk factor for local recurrence (p = 0.029). However, there were no significant differences on preoperative computed tomography findings between the pancreatic invasion and non-invasion groups.

Conclusion: DP is a reasonable procedure for pancreas-abutting RPS located at the LUQ when both complications and complete resection are considered.

Citing Articles

Comprehensive treatment strategy for improving surgical resection rate of retroperitoneal sarcomas: a histology-specific approach narrative review.

Garcia-Ortega D Front Oncol. 2024; 14:1432900.

PMID: 39435281 PMC: 11491436. DOI: 10.3389/fonc.2024.1432900.


Evaluation of AJCC staging system and proposal of a novel stage grouping system in retroperitoneal liposarcoma: the Fudan Zhongshan experience.

Fan P, Tao P, Wang Z, Wang J, Hou Y, Lu W Front Oncol. 2024; 14:1373762.

PMID: 38601763 PMC: 11004455. DOI: 10.3389/fonc.2024.1373762.


Resection of previously inoperable retroperitoneal liposarcoma.

Maclean E, Delriviere L, Johansson M, Hodder R BMJ Case Rep. 2023; 16(11).

PMID: 37945281 PMC: 10649782. DOI: 10.1136/bcr-2023-256479.

References
1.
Rhu J, Cho C, Lee K, Park H, Park J, Choi Y . Radical Nephrectomy for Primary Retroperitoneal Liposarcoma Near the Kidney has a Beneficial Effect on Disease-Free Survival. World J Surg. 2017; 42(1):254-262. DOI: 10.1007/s00268-017-4157-6. View

2.
Knaebel H, Diener M, Wente M, Buchler M, Seiler C . Systematic review and meta-analysis of technique for closure of the pancreatic remnant after distal pancreatectomy. Br J Surg. 2005; 92(5):539-46. DOI: 10.1002/bjs.5000. View

3.
Flacs M, Faron M, Mir O, Mihoubi F, Sourouille I, Haddag-Miliani L . Postoperative Outcome of Surgery with Pancreatic Resection for Retroperitoneal Soft Tissue Sarcoma: Results of a Retrospective Bicentric Analysis on 50 Consecutive Patients. J Gastrointest Surg. 2020; 25(9):2299-2306. DOI: 10.1007/s11605-020-04882-2. View

4.
Toulmonde M, Bonvalot S, Meeus P, Stoeckle E, Riou O, Isambert N . Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Ann Oncol. 2014; 25(3):735-742. PMC: 4433510. DOI: 10.1093/annonc/mdt577. View

5.
Bonvalot S, Rivoire M, Castaing M, Stoeckle E, Cesne A, Blay J . Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2008; 27(1):31-7. DOI: 10.1200/JCO.2008.18.0802. View